• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿休克时抗凝血酶III水平降低:是弥散性血管内凝血还是非特异性蛋白质消耗?

Low antithrombin III in neonatal shock: DIC or non-specific protein depletion?

作者信息

Schmidt B K, Muraji T, Zipursky A

出版信息

Eur J Pediatr. 1986 Dec;145(6):500-3. doi: 10.1007/BF02429051.

DOI:10.1007/BF02429051
PMID:3816852
Abstract

Low antithrombin III (AT III) levels in shock are usually ascribed to disseminated intravascular coagulation (DIC). However, decreased activities of clotting factors and their inhibitors could reflect a generalised fall in plasma proteins rather than DIC. AT III and albumin were compared in 48 asphyxiated and non-asphyxiated newborn rabbits (pH 6.70-7.30). Both AT III and albumin were markedly decreased in the sickest animals and there was a direct linear relationship between the two proteins (P less than 0.001). Similar results were obtained in ten newborn infants suffering from shock and haemorrhagic diathesis. In all cases AT III and albumin were decreased below the normal range and significantly correlated (P less than 0.01). Our findings suggest that AT III is not a useful diagnostic marker of DIC. Further, a similar fall of clottable and non-clottable proteins in shock questions the general assumption that the ensuing coagulopathy is due to intravascular coagulation.

摘要

休克时抗凝血酶III(AT III)水平降低通常归因于弥散性血管内凝血(DIC)。然而,凝血因子及其抑制剂活性降低可能反映血浆蛋白普遍减少,而非DIC。对48只窒息和未窒息新生兔(pH 6.70 - 7.30)的AT III和白蛋白进行了比较。病情最严重的动物中,AT III和白蛋白均显著降低,且两种蛋白之间存在直接线性关系(P < 0.001)。在10例患有休克和出血素质的新生儿中也得到了类似结果。所有病例中,AT III和白蛋白均降至正常范围以下,且显著相关(P < 0.01)。我们的研究结果表明,AT III并非DIC的有用诊断标志物。此外,休克时可凝固和不可凝固蛋白类似程度的降低,对随之而来的凝血病是由于血管内凝血这一普遍假设提出了质疑。

相似文献

1
Low antithrombin III in neonatal shock: DIC or non-specific protein depletion?新生儿休克时抗凝血酶III水平降低:是弥散性血管内凝血还是非特异性蛋白质消耗?
Eur J Pediatr. 1986 Dec;145(6):500-3. doi: 10.1007/BF02429051.
2
Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation.在患有弥散性血管内凝血的重症患者中,血清白蛋白水平可预测抗凝血酶III制剂使用前后的抗凝血酶III活性。
Shock. 2007 Feb;27(2):139-44. doi: 10.1097/01.shk.0000239762.90335.68.
3
Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.腹部脓毒症所致弥散性血管内凝血中的凝血功能障碍:凝血酶原片段1+2及其他标志物的测定
Haemostasis. 1992;22(1):17-24. doi: 10.1159/000216287.
4
Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases.
Intensive Care Med. 1992;18(4):202-5. doi: 10.1007/BF01709832.
5
Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?凝血筛查试验能否检测出患病新生儿体内凝血酶和纤溶酶生成增加?
Thromb Haemost. 1993 May 3;69(5):418-21.
6
Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).疑似弥散性血管内凝血(DIC)的危重症患者的血浆前激肽释放酶、因子 XII、抗凝血酶 III、C1(-)抑制剂和α2-巨球蛋白
Am J Clin Pathol. 1984 Oct;82(4):396-404. doi: 10.1093/ajcp/82.4.396.
7
[Antithrombin III substitution in patients in shock].
Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(6):806-16.
8
Hageman factor and disseminated intravascular coagulation (DIC) in newborns and rabbits.
Pediatr Res. 1977 Aug;11(8):916-20. doi: 10.1203/00006450-197708000-00013.
9
Fibronectin in meningococcal sepsis. Correlation with antithrombin III and protein C.脑膜炎球菌败血症中的纤连蛋白。与抗凝血酶III和蛋白C的相关性。
Acta Paediatr Scand. 1990 Jan;79(1):73-6. doi: 10.1111/j.1651-2227.1990.tb11334.x.
10
Hypercoagulability and DIC in high-risk infants.高危婴儿的高凝状态与弥散性血管内凝血
Semin Thromb Hemost. 1998;24(5):463-6. doi: 10.1055/s-2007-996040.

本文引用的文献

1
Thrombocytopenia in the high-risk infant.高危婴儿的血小板减少症
J Pediatr. 1980 Nov;97(5):791-4. doi: 10.1016/s0022-3476(80)80272-1.
2
Exchange between intravascularly and extravascularly injected radioiodinated fibrinogen and its in vivo derivatives.
J Lab Clin Med. 1980 Jun;95(6):842-56.
3
Efficiency of heparin in the treatment of newborn infants with respiratory distress syndrome and disseminated intravascular coagulation.
Eur J Pediatr. 1980;133(1):47-9. doi: 10.1007/BF00444754.
4
Disseminated intravascular coagulation: a clinical/laboratory study of 48 patients.弥散性血管内凝血:48例患者的临床/实验室研究
Ann N Y Acad Sci. 1981;370:843-50. doi: 10.1111/j.1749-6632.1981.tb29790.x.
5
Disseminated intravascular coagulation. Findings in 346 patients.弥散性血管内凝血。346例患者的研究结果。
Thromb Haemost. 1980 Feb 29;43(1):28-33.
6
Persistent antithrombin III deficiency: risk factor for thromboembolic complications in neonates small for gestational age.持续性抗凝血酶III缺乏:小于胎龄儿新生儿血栓栓塞并发症的危险因素。
J Pediatr. 1984 Aug;105(2):310-4. doi: 10.1016/s0022-3476(84)80138-9.
7
Plasma elimination of antithrombin III (heparin cofactor activity) is accelerated in term newborn infants.
Eur J Pediatr. 1984 Feb;141(4):225-7. doi: 10.1007/BF00572765.
8
Low antithrombin III levels in neonates with idiopathic respiratory distress syndrome: poor prognosis.患有特发性呼吸窘迫综合征的新生儿抗凝血酶III水平低:预后不良。
Pediatr Res. 1984 Mar;18(3):273-6. doi: 10.1203/00006450-198403000-00012.
9
Antithrombin 3 and diseases.抗凝血酶3与疾病
Am J Clin Pathol. 1967 Jul;48(1):69-80. doi: 10.1093/ajcp/48.1.69.
10
Exchange transfusion with citrated whole blood for disseminated intravascular coagulation.用枸橼酸盐全血进行换血疗法治疗弥散性血管内凝血。
J Pediatr. 1971 Mar;78(3):415-9. doi: 10.1016/s0022-3476(71)80220-2.